Search research articles
Contact Us
Filters
Showing results (91-100 of 177) with videos related to
Page
of 18
Sort By:
Therapie
|
January 1, 1981
[Utilization of lidocaïne in the acute phase of myocardial infarction (author's transl)]
A Egre, P Djiane, A Serradimigni, et al.
Connective Tissue Research
|
January 1, 1977
Osteogenesis imperfecta: morphological, histochemical and biochemical aspects. Modifications induced by (+)-catechin
G Cetta, L Lenzi, M Rizzotti, et al.
Matrix (Stuttgart, Germany)
|
March 1, 1990
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes
R Tenni, A Rossi, M Valli, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity
R Tenni, G Cetta, K Dyne, et al.
Therapie
|
March 1, 1980
[Study of possible modifications of the estrous cycle induced by antiepileptic treatment during the perinatal period in the rat]
B Bruguerolle, G Jadot, M Valli, et al.
Human Mutation
|
January 8, 2000
Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online
M Mottes, M Gomez Lira, F Zolezzi, et al.
American Journal of Medical Genetics
|
May 3, 1996
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta
K M Dyne, M Valli, A Forlino, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1977
[The effects of age and sex on the acute toxicity of two barbiturate anesthetics in rats]
B Bruguerolle, E Mesdjian, M Valli, et al.
L'Encephale
|
July 1, 1990
[Erythrocyte membrane transport of tyrosine and tryptophan and plasma level of MHPG in depressive disorders]
C Lançon, R Jeanningros, M Valli, et al.
Neuropsychobiology
|
January 1, 1988
Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients
J M Azorin, F Karege, M Valli, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 177) with videos related to
Sort By:
Page
of 18
Therapie
|
January 1, 1981
[Utilization of lidocaïne in the acute phase of myocardial infarction (author's transl)]
A Egre, P Djiane, A Serradimigni, et al.
Connective Tissue Research
|
January 1, 1977
Osteogenesis imperfecta: morphological, histochemical and biochemical aspects. Modifications induced by (+)-catechin
G Cetta, L Lenzi, M Rizzotti, et al.
Matrix (Stuttgart, Germany)
|
March 1, 1990
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes
R Tenni, A Rossi, M Valli, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity
R Tenni, G Cetta, K Dyne, et al.
Therapie
|
March 1, 1980
[Study of possible modifications of the estrous cycle induced by antiepileptic treatment during the perinatal period in the rat]
B Bruguerolle, G Jadot, M Valli, et al.
Human Mutation
|
January 8, 2000
Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online
M Mottes, M Gomez Lira, F Zolezzi, et al.
American Journal of Medical Genetics
|
May 3, 1996
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta
K M Dyne, M Valli, A Forlino, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1977
[The effects of age and sex on the acute toxicity of two barbiturate anesthetics in rats]
B Bruguerolle, E Mesdjian, M Valli, et al.
L'Encephale
|
July 1, 1990
[Erythrocyte membrane transport of tyrosine and tryptophan and plasma level of MHPG in depressive disorders]
C Lançon, R Jeanningros, M Valli, et al.
Neuropsychobiology
|
January 1, 1988
Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients
J M Azorin, F Karege, M Valli, et al.
Page
of 18